|
Adamis AP, Barry Meklir B, and Joyce NC. 1991, In situ injury-induced release of basic-fibroblast growth factor from corneal epithelial cells. Am J Pathol. 139:961-967 Amano S, Rohan R, Kuroki M, Tolentino M, Adamis AP. 1998, Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci. 39:18-22 Anand-Apte, B., Pepper, M. S., Voest, E., Montesano, R., Olsen, B., Murphy, G., Apte, S. S.and Zetter, B. 1997, Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest Ophthalmol Vis Sci, 38: 817-23. Aumailley M, Krieg T. 1996, Laminins: A family of diverse multifunctional molecules of basement membrane. J Invest Dermatol.106:209-214 Azuara-Blanco A, Pillai CT, Dua HS. 1999, Amniotic membrane transplantation for ocular surface reconstruction. Br J Ophthalmol 83:399-402. Bachsich P, Wyburn GM. 1947, The significance of the mucoprotein content on the survival of homografts of cartilage and cornea. Proc Roy Soc Edin. 62:321-327 Ballaun C, Weninger W, Uthman A, Weich H, Tschachler E. 1995, Human keratinocytes express the three major splice forms of vascular endothelial growth factor. J Invest Dermatol. 104:7-10 Bednarz J, Weich HA, Rodokanaki-von Schrenck A, Engelmann K. 1995, Expression of genes encoding growth factors and growth factor receptors in differentiated and dedifferentiated human corneal endothelial cells. Cornea 14:372-381 Bigg, H. F., Shi, Y. E., Liu, Y. E., Steffensen, B.and Overall, C. M. 1997, Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2. J Biol Chem, 272:15496-500. Boudreau N, Sympson CJ, Werb Z, et al. 1995, Supression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267:891-893. Boudreau N, Werb Z, Bissell MJ, et al. 1996, Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrwal from the cell cycle. Proc Natl Acad Sci USA 93:3500-3513. Brown D, Chwa MM, Opbroek A, Kenney MC. 1993, Keratoconus corneas: increased gelatinolytic activity appears after modification of inhibitors. Curr Eye Res 12:571-81. Bultmann S, You L, Spandau U, et al. 1999, Amniotic membrane down-regulates chemokine expression in human keratocytes. Invest Ophthalmol Vis Sci 40:S578 Castle VP, Dixit VM, Polverini PJ. 1997, Thrombospondin-1 suppresses tumorigenesis and angiogenesis in serum- and anchorage- independent NIH 3T3 cells. Lab Invest 77:51-61. Chen WYW, Mui MM, Kao WWY, Liu CY, Tseng SCG. 1994, Conjunctival epithelial cells do not transdifferentiate in organotypic cultures: expression of K12 keratin is restricted to corneal epithelium. Curr Eye Res. 13:765-778 Cogan DG. 1949, Vascularization of the cornea: its experimental induction by small lesions and a new theory of its pathogenesis. Arch Ophthalmol. 41:406-416 Conners MS, Urbano F, Vafeas C, Stoltz RA, Dunn MW, Laniado-Schwartzman M. 1997, Alkali burn-induced synthesis of inflammatory eicosanoids in rabbit corneal epithelium. Invest Ophthalmol Vis Sci. 38:1963-1971 Cooper TW, Eisen AZ, Stricklin GP, Welgus HG. 1985, Platelet derived collagenase inhibitor: Characterization and subcellular localization. Proc Natl Acad Sci U S A 82:2779-2783. Corcoran, M. L., Hewitt, R. E., Kleiner, D. E., Jr.and Stetler-Stevenson, W. G. 1996, MMP-2: expression, activation and inhibition. Enzyme Protein, 49, 7-19. Cornelius LA, Nehring LC, Roby JD, Parks WC, Welgus HG. 1995, Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration. J Invest Dermatol 105:170-6. Dana MR, Zhu SN, Yamada J. 1998, Topical modulation of interleukin-1 activity in corneal neovascularization. Cornea 17:403-409. Detmar M, Yeo KT, Nagy JA, et al. 1995, Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Invest Dermatol. 105: 44-50 Dinarello CA. Interleukin-1. 1998, In: Thomson A, ed. The cytokine handbook. 3 ed. San Diego: Academic Press, 35-72. Dua HS, Azuara-Blanco A. 1999, Amniotic membrane transplantation. Br J Ophthalmol 83:748-752. Eisenberg SP, Evans RJ, Arend WP, et al. 1990, Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343:341-346. Eliason J. Angiogenic activity of the corneal epithelium. 1985, Exp Eye Res. 41:721-732 Eliason JA, Elliott JP. Proliferation of vascular endothelial cells stimulated in vitro by corneal epithelium. 1987, Invest Ophthalmol Vis Sci. 28:1963-1969 Fini, M. E., Parks, W. C., Rinehart, W. B., Girard, M. T., Matsubara, M., Cook, J. R., West-Mays, J. A., Sadow, P. M., Burgeson, R. E., Jeffrey, J. J., Raizman, M. B., Krueger, R. R.and Zieske, J. D. 1996, Role of matrix metalloproteinases in failure to re-epithelialize after corneal injury. Am J Pathol, 149, 1287-302. Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I. A heparin-binding angiogenic protein-basic fibroblast growth factor-is stored within basement membrane. 1988, Am J Pathol. 130:393-400 Form DM, Pratt BM, Madri JA. 1986, Endothelial cell proliferation during angiogenesis: In vitro modulation by basement membrane components. Lab Invest. 55:521-530 Fortunato SJ, Menon R, Lombardi SJ. Collagenolytic enzymes (gelatinases) and their inhibitors in human amniochorionic membrane. 1997, Am J Obstet Gynecol 177:731-741. Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG, Werner S. 1995, Regulation of vascular endothelial growth factor expression in cultured keratinocytes. J Biol Chem. 270:12607-12613 Friedlander M, Aguilar E, Gigliotti B, Leonard M, Dorrel M. Recombinant PEX, a non-catalytic fragment of matrix metalloproteinase-2 (MMP-2) inhibits corneal neovascularization. 1999, Invest Ophthalmol Vis Sci 40:S194. Galis ZS, Sukhova GK, Libby P. 1995, Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue. FASEB J 9:974-980. Gillis PR, Volpert OV, Bouck NP. 1997, Isolation and characterization of a novel inhibitor of angiogenesis from the corneal stroma. ARVO Abstracts. Invest Ophthalmol Vis Sci. 38:S514. Glatt HJ, Vu MT, Burger PC, Klintworth GK. 1985, Effect of irradiation on vascularization of corneas grafted onto chorioallantoic membrane. Invest Ophthalmol Vis Sci. 26:1533-1542 Gomes JAP, Pena JDO, Komagome CM, Santos N, Loma-Filho AAS,Rizzo LV. 2000, Cytokines on fresh and DMSO or glycerol preserved amniotic membrane. Invest Ophthalmol Vis Sci 41:S455 Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP. 1997, Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74:111-22. Greene, J., Wang, M., Liu, Y. E., Raymond, L. A., Rosen, C.and Shi, Y. E. 1996. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase-4. J Biol Chem, 271:30375-80. Gupta A, Kapadia L, Bajwa KR, Li Y, Bennett J. 1997, Localization of TIMP-3 in mouse cornea. ARVO Abstracts. Invest Ophthalmol Vis Sci. 38:S514 Haas TL, Davis SJ, Madri JA. 1998, Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J Biol Chem273:3604-10. Hanemaaijer, R., Koolwijk, P., le Clercq, L., de Vree, W. J.and van Hinsbergh, V. W. 1993, Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. Biochem J, 296, 803-9. Hannum CH, Wilcox CJ, Arend WP, et al. 1990, Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343:336-340. Herron GS, Banda MJ, Clark EJ, Gavrilovic J, Werb Z. 1986, Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J Biol Chem 261:2814-8. Hiscott P, Sorokin L, Nagy ZZ, Schlotzer-Schrehardt U, Naumann GOH. 1996, Synthesis of thrombospondin 1 by keratocytes. ARVO Abstracts. Invest Ophthalmol Vis Sci. 37:S188 Houck KA, Ferrara N, Winer J, Cachianes G, Li B and Leung DW. 1991, The vascular endothelial growth factor family: identification of a fourth moelcular species and characterization of alternative splicing of RNA. Mol Endocrinol. 5:1806-1814 Huang AJW, Watson BD, Hernandez E, Tseng SCG. 1988, Induction of conjunctival transdifferentiation on vascularized corneas by photothrombotic occlusion of corneal neovascularization. Ophthalmol. 95:228-235 Huang AJW, Tseng SCG. 1991, Corneal epithelial wound healing in the absence of limbal epithelium. Invest Ophthalmol Vis Sci. 32:96-105 Huang AJW, Thio IM, Hernandez E. 1993, Modulation of corneal vascularization by conjunctival epithelium. ARVO Abstracts. Invest Ophthalmol Vis Sci. 34:S822 Huang AJW, Yu K, Yoshino K, Pflugfelder SC. 1994, Regulation of conjunctival differentiation and corneal vascularization. ARVO Abstracts. Invest Ophthalmol Vis Sci. 35: S1559 Huang AJW, Li DQ, Hernandez E. 2000, Up-regulation of collagenase (MMP-1 and -13) and gelatinases (MMP-2 and -9) in vascularized rabbit corneal epithelium. Invest Ophthalmol Vis Sci 41:S833. Huang S, Xie K, Bucana CD, Ullrich SE, Bar-Eli M. 1996, Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis. Clin Cancer Res 2:1969-1979. Hurme M, Lahdenpohja N, Santtila S. 1998, Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases. Ann Med 30:469-473. Jackson CJ, Nguyen M. 1997, Human microvascular endothelial cells differ from macrovascular endothelial cells in their expression of matrix metalloproteinases. Int J Biochem Cell Biol 29:1167-77. Jackson, J. R., Seed, M. P., Kircher, C. H., Willoughby, D. A.and Winkler, J. D. 1997, The codependence of angiogenesis and chronic inflammation. Faseb J, 11, 457-65. Johnson, M. D., Kim, H. R., Chesler, L., Tsao-Wu, G., Bouck, N.and Polverini, P. J. 1994, Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol, 160:194-202. Kawashima Y, Saika S, Yamanaka O, et al. 1997, Immunolocalization of TIMPs and MMPs in healing subconjunctival tissue of humans and in cultured human subconjunctival fibroblasts. ARVO Abstracts. Invest Ophthalmol Vis Sci. 38:S267 Kenny MC, Chwa M, Opbroek AJ, Brown DJ. 1994, Increased gelatinolytic activity in keratoconus keratocyte cultures. Cornea 13:114-124. Kenney, M. C., Chwa, M., Alba, A., Saghizadeh, M., Huang, Z. S.and Brown, D. J. 1998, Localization of TIMP-1, TIMP-2, TIMP-3, gelatinase A and gelatinase B in pathological human corneas. Curr Eye Res, 17:238-46. Kenyon KR, Tseng SCG. 1989, Limbal autograft transplantation for ocular surface disorders. Ophthalmol. 96:709-723 Kenyon BM, Voest EE, Chen CC, Flynn E, Folkman J, D''Amato RJ. 1996, A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci 37:1625- Kernacki, K. A., Goebel, D. J., Poosch, M. S. and Hazlett, L. D. 1998, Early TIMP gene expression after corneal infection with Pseudomonas aeruginosa. Invest. Ophthalmol. Vis. Sci. 39:331-5. Kim JC, Tseng SCG. 1995, Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 14:473-484. Kim JC, Kim JS, Han TW. Amniotic Membrane transplantation in corneal ulcer. Presented at the Second Meeting of the Asia Pacific Society of Cornea and Refractive Surgery, Chiba, Japan, Feb. 16th, 2000. Klintworth GK. (a). Use of the cornea to assay for angiogenic activity. 1990, In: Klintworth GK, ed. Corneal angiogenesis: A comprehensive critical review. New York, NY: Springer-Verlag; 13-15. Klintworth GK. (b). 1990, Hypotheses about the pathogenesis of corneal vascularization. In: Klintworth GK, ed. Corneal angiogenesis: A comprehensive critical review. New York, NY: Springer-Verlag; 23-29. Klintworth GK. (c). 1990, Nature of angiogenic factor. In: Klintworth GK, ed. Corneal angiogenesis: A comprehensive critical review. New York, NY: Springer-Verlag; 45-50. Kobayashi A, Inana G, Meller D, et al. Differential gene expression by human cultured umbilical vein endothelial cells on amniotic membrane. Presented at the 4th Ocular Surface and Tear Conference, Miami, Fl, May 14th, 1999. Kubota Y, Kleinman HK, Martin GR, Lawley TJ. 1988, Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol. 1589-1598 Kuzuya M, Kinsella JL. 1994, Induction of endothelial cell differentiation in vitro by fibroblast-derived soluble factors. Exp Cell Res. 215:310-318 Kvanta A. 1995, Expression and regulation of vascular endothelial growth factor in choroidal fibroblasts. Curr Eye Res. 14:1015-1020 Lacraz S, Nicod LP, Chicheportiche R, Welgus HG, Dayer JM. 1995, IL-10 inhibits metalloproteinases and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 96:2304-2310. Lamoreaux WJ, Fitzgerald MEC, Reiner A, Hasty KA, Charles ST. 1996, Vascular endothelial growth factor (VEGF) increases matrix metalloproteinase production by human microvascular endothelial cells in vitro. ARVO Abstracts. Invest Ophthalmol Vis Sci. 37:S793 Leco, K. J., Khokha, R., Pavloff, N., Hawkes, S. P.and Edwards, D. R. 1994, Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem, 269:9352-60. Lee SH, Tseng SCG. 1997, Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol 123:303-312. Levy AP, Levy NS, Wegner S, Goldberg MA. 1995, Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem. 270:13333-13340 Levy AP, Levy NS, Goldberg MA. 1996, Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem. 271:2746-2753 Li CH, McConnell A, Garcia J, Hernandez E, Huang AJW. 1996, Expression of vascular endothelial growth factor in rabbit ocular surface epithelia. ARVO Abstracts. Invest Ophthalmol Vis Sci. 37:S863 Li DQ, Tseng SCG. 1995, Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface. J Cell Physiol. 163:61-79 Li YY, Feldman A, Sun Y, McTiernan CF. 1998, Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Circulation 98:1728-1734. Lu P, Ye H, Maeda M, Azar D. 1999, Immunolocalization and gene expression of matrilysin during corneal wound healing. Invest Ophthalmol Vis Sci 40:20-27. Malefyt RDW, Moore KW. Interleukin 10. 1998, In: Thomson A, ed. The cytokine handbook. 3 ed. San Diego: Academic Press, 333-364. Mann I, Pirie A, Pullinger BD. 1948, An experimental and clinical study of the reaction of the anterior segment of the eye to chemical injury, with special reference to chemical warfare agents. Br J Ophthalmol Suppl. 13:5-171 Maseruka H, Bonshek RE, Tullo AB, Ridgway AEA, Zardi L. 1997, Tenascin-C (TN-C) and thrombospondin-1 (TSP-1) in the human corneal angiogenic cascade. ARVO Abstracts. Invest Ophthalmol Vis Sci. 38:S701 Matsubara, M (a), Zieske, J. D.and Fini, M. E. 1991, Mechanism of basement membrane dissolution preceding corneal ulceration. Invest Ophthalmol Vis Sci, 32:3221-37. Matsubara M (b), Girard MT, Kublin CL, Cintron C, Fini ME. Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodeling cornea. Dev Biol 1991;147:425-439. Maybodi M, Harvey HD, Williams JM, Pepose JS, Fleming TP. 1996, Vascular endothelial growth factor is expressed in cornea. ARVO Abstracts. Invest Ophthalmol Vis Sci. 37:S1139 McCracken, J. S., Burger, P. C.and Klintworth, G. K. 1979, Morphologic observations on experimental corneal vascularization in the rat. Lab Invest, 41:519-524 Meller D, Tseng SCG. 1999, Conjunctival epithelial cell differentiation on amniotic membrane. Invest Ophthalmol Vis Sci 40:878-886. Meller D, Pires RTF, Tseng SCG. 2000, Ex Vivo expansion of human limbal epithelial stem cells on amniotic membrane. Invest Ophthalmol Vis Sci 41:S454. Meyer RF, Chaffee E. 1940, The mucopolysaccharide acid of the cornea and its enzymatic hydrolysis. Am J Opthalmol. 23:1320-1325 Mertz PM, DeWitt DL, Stettler-Stevenson WG, Wahl LM. 1994, Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. J Biol Chem 269:21322-9 Mignatti, P.and Rifkin, D. B. 1996, Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein, 49:117-37. Montesano R, Pepper MS Orci L. 1993, Paracrine induction of angiogenesis in vitro by Swiss 3T3 fibroblasts. J Cell Sci. 105:1013-1024 Murphy, A. N., Unsworth, E. J.and Stetler-Stevenson, W. G. 1993, Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol, 157:351-8. Na BK, Hwang JH, Kim JK, Shin EJ, Kim JS, Jeong JM, Song CY. 1999, Analysis of human amniotic membrane components as proteinase inhibitors for development of therapeutic agent of recalcitrant keratitis. Trophoblast research 13:453-466 Nakayasu K, Hayashi N, Okisaka S, Sato N. 1992, Formation of capillary-like tubes by vascular endothelial cells cocultivated with keratocytes. Invest Ophthalmol Vis Sci. 33:3050-3057 Paradowska E, Blach-Olszewska Z, Cgejdel E. 1997, Constitutive and induced cytokine production by human placenta at term. Placenta 18:441-446. Peek R, van Gelderen BE, Bruinenberg M, Kijlstra A. 1998, Molecular cloning of a new angiopoietinlike factor from the human cornea. Invest Ophthalmol Vis Sci. 39:1782-1788 Pepper, M. S. 1997, Manipulating angiogenesis. From basic science to the bedside. Arterioscler Thromb Vasc Biol, 17:605-19. Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Sakela O, Alitalo K. 1994, Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J Biol Chem. 269:6271-6274 Pintucci, G., Bikfalvi, A., Klein, S.and Rifkin, D. B. 1996, Angiogenesis and the fibrinolytic system. Semin Thromb Hemost, 22:517-24. Prabhasawat P, Barton K, Burkett G, et al. 1997, Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology 104:974-985 Rabbani SA. 1998, Metalloproteases and urokinase in angiogenesis and tumor progression. In Vivo 12:135-42. Ries, C.and Petrides, P. E. 1995, Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe Seyler, 376:345-55. Riley GP, Harrall RL, Watson PG, Cawston TE, Hazleman BL. 1995, Collagenase (MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis. Eye 9:703-18. Rowe TF, King LA, MacDonald PC, Casey ML. 1997, Tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 expression in human amnion mesenchymal and epithelial cells. Am J Obstet Gynecol 176:915-921. Sakamoto T, Sakamoto H, Murphy TL, et al. 1995, Vessel formation by choroidal endothelial cells in vitro is modulated by retinal pigment epithelial cells. Arch Ophthalmol. 113:512-520 Schnaper HW, Grant DS, Stetler-Stevenson WG, et al. 1993, Type IV collagenase(s) and TIMPs modulate endothelial morphogenesis in vitro. J Cell Physiol. 156:235-246 Shimazaki J, Yang H, Tsubota K. 1997, Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns. Ophthalmology 104:2068-2076. Shimazaki J, Shinozaki N, Tsubota K. 1998, Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon. Br J Ophthalmol 82:235-240. Smith RS, Smith TJ, Blieden TM, Phipps RP. 1997, Fibroblasts as sentinel cells: Synthesis of chemokines and regulation of inflammation. Am J Pathol. 151:317-322 Smith VA, Hoh HB, Easty DL. 1999, Role of ocular matrix metalloproteinases in peripheral ulcerative keratitis. Br J Ophthalmol 83:1376-1383. Solomon A, Monroy D, Ji Z, et al. Suppression of epithelial expression of IL-1 βby the amniotic membrane. Presented at the 4th Ocular Surface and Tear Conference, Miami, Fl, May 14th, 1999. Sonoda, K., Sakamoto, T., Yoshikawa, H., Ashizuka, S., Ohshima, Y., Kishihara, K., Nomoto, K., Ishibashi, T.and Inomata, H. 1998, Inhibition of corneal inflammation by the topical use of Ras farnesyltransferase inhibitors: selective inhibition of macrophage localization. Invest Ophthalmol Vis Sci, 39:2245-51. Soubrane G, Jerdan J, Karpouzas I, et al. 1990, Binding of basic fibroblast growth factor to normal and neovascularized rabbit cornea. Invest Ophthalmol Vis Sci. 31:323-333 Stearns ME, Rhim J, Wang M. 1999, Interleukin 10 (IL-10) inhibition of primary human prostate cell-induced angiogenesis:IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion. Clin Cancer Res 5:189-196. Steen B, Sarman S, Fagerholm P, Seregard S, Kvanta A. 2000, Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization. Invest Ophthalmol Vis Sci 41:S833. Stoltz RA, Conners MS, Gerritsen ME, Abraham NG, Laniado-Schwartzman M. 1996, Direct stimulation of limbal microvessel endothelial cell proliferation and capillary formation in vitro by a corneal-derived eicosanoid. Am J Pathol. 148:129-139 Strieter RM, Kunkel SL, Elner VM, et al. 1992, Interleukin 8: A corneal factor that induces neovascularization. Am J Pathol. 141:1279-1284 Sunderkotter C, Beil W, Roth J, Sorg C. 1991, Cellular events associated with inflammatory angiogenesis in the mouse cornea. Am J Pathol 138:931-939. Tei M, Koizumi N, Takagi Y, Kinoshita S. 2000, cDNA macroarray used to analyze the gene expression change in human corneal epithelium on amniotic membrane. Invest Ophthalmol Vis Sci 41:S757. Thomas KA. 1996, Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem. 271:603-606 Trautman MS, Collmer D, Edwin SS, White W, Mitchell MD. Dudley DJ. 1997, Expression of interleukin-10 in human gestational tissues. J Soc Gynecol Investig 4:247-253. Tsai RJF, Sun TT, Tseng SCG. Comparison of limbal and conjunctival autograft transplantation in corneal surface reconstruction in rabbits. Ophthalmol. 1990;97:446-455 Tsai R, Chen JK. 1992, In vitro reconstruction of human conjunctival tissue from collagen and cultured conjunctival cells. Tiss Cult Res Commun. 11: 315-318 Tsai R, Ho Y, Chen JK. 1994, The effects of fibroblasts on the growth and differentiation of human bulbar conjunctival epithelial cells in an in vitro conjunctival equivalent. Invest Ophthalmol Vis Sci. 35:2865-2875 Tsai RJF, Tseng SCG. 1994, Human allograft limbal transplantation for corneal surface reconstrcution. Cornea 13:389-400 Tsai RJF, Tseng, SCG. 1995, Effect of stromal inflammation on the outcome of limbal transplantation for corneal surface reconstruction. Cornea 14:439-449. Tsai RJF. 2000, The cytokine studies of organotypic cultures of ocular surface epithelium on amniotic membrane. Invest Ophthalmol Vis Sci 41:S454. Tseng SCG. 1989, Concept and application of limbal stem cells. Eye 3:141-157 Tseng SCG, Prabhasawat P, Lee SH. 1997, Amniotic membrane transplantation for conjunctival surface reconstruction. Am J Ophthalmol 124:765-774. Tseng SCG, Prabhasawat P, Barton K, et al. 1998, Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol 116:431-441. Tsubota K, Toda I, Saito H, Shinozaki N, Shimazaki J. 1995, Reconstruction of the corneal epithelium by limbal allograft transplantation for severe ocular surface disorders. Ophthalmol. 102:1486-1443. Tsubota K, Satake Y, Ohyama M, et al. 1996, Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol 122:38-52. Twining SS, Peng H, Sternard H. 2000, Angiostatin production by human corneal stromal cells. Invest Ophthalmol Vis Sci. 41:S118. Unemori EN, Ferrara N, Bauer EA, Amento EP. 1992, Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 153:557-62. van Setten GB, Fagerholm P, Cuevas-Sanchez P. 1995, Presence of basic fibroblast growth factor in corneal epithelium. Ophthalmic Res. 27:317-321 van Setten GB. 1997, Vascular endothelial growth factor (VEGF) in normal human corneal epithelium: Detection and physiological importance. Acta Ophthalmol Scand. 75:649-652 Villaschi S and Nicosia RF. 1994, Paracrine interactions between fibroblasts and endothelial cells in a serum-free coculture model. Lab Invest. 291:291-299 Vlodavsky I, Klasgsbrun M, Folkman J. Storage of heparin-binding endothelial cell growth factors in the cornea: a new mechanism for corneal neovascularization. In BenEzra D, Ryan SJ, Glaser DM, Murphy RP, Eds. Ocular Circulation and Neovascularization. Martinus Nijhoff/Dr W. Junk, Dordrecht, 1987. Vranka, J. A., Johnson, E., Zhu, X., Shepardson, A., Alexander, J. P., Bradley, J. M., Wirtz, M. K., Weleber, R. G., Klein, M. L.and Acott, T. S. 1997, Discrete expression and distribution pattern of TIMP-3 in the human retina and choroid. Curr Eye Res, 16:102-10. Wang M, Liu YE, Greene J, Sheng S, Fuchs A, Rosen EM, Shi Y. E. 1997, Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4. Oncogene 14:2767-74. Watanabe H, Nakanishi I, Yamashita K, Hayakawa T, Okada Y. 1993, Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. J Cell Sci 104:991-9. Wei ZG, Sun TT, Lavker RM. 1996, Rabbit conjunctival and corneal epithelial cells belong to two separate lineages. Invest Ophthalmol Vis Sci. 37:523-533 Woessner, J. F. 1998, The matrix metalloproteinase family. In Matrix Metalloproteinases (Eds. W. C. Parks, R. P. Mecham) Pp. 1-14. Academic Press, San Diego. Wong HC, Bouton M, Marshall J, Clark P. 1987, Growth of retinal capillary endothelia using pericyte conditioned medium. Invest Ophthalmol Vis Sci. 28:1767-1775 Wu, I.and Moses, M. A. 1998, Molecular cloning and expression analysis of the cDNA encoding rat tissue inhibitor of metalloproteinase-4. Matrix Biol, 16:339-42. Ye, H. Q.and Azar, D. T. 1998, Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing. Invest Ophthalmol Vis Sci, 39:913-21. Yu, A. E., Murphy, A. N.and Stetler-Stevenson, W. G. 1998, 72-kDa gelatinase (gelatinase A): structure, activation, regulation, and substrate specificity. In Matrix Metalloproteinases (Eds. W. C. Parks, R. P. Mecham) Pp. 85-113. Academic Press, San Diego. Zhang Y, McCluskey K, Fujii K, Wahl LM. 1998, Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms. J Immunol 161:3071-6.
|